Key result
Pulmonary embolism linked to worse health-related quality of life at 3 and 12 months.
Why the study?
It has not been conclusively established whether and to what extent pulmonary embolism affects health-related quality of life.
Does pulmonary embolism independently reduce long-term health-related quality of life compared to matched controls from the general population?
Cohort (n=4,063)
Yes
Does pulmonary embolism independently reduce long-term health-related quality of life compared to matched controls from the general population?
Effect estimate: Adjusted difference -0.04 (95% CI -0.06 to -0.039)
Pulmonary embolism is independently associated with a moderate, persistent decrease in health-related quality of life up to 12 months post-event, comparable to other cardiopulmonary diseases.
May warrant HrQoL monitoring in PE follow-up; leaves open whether interventions improve outcomes.
AIMS: It has not been conclusively established whether and to what extent pulmonary embolism (PE) affects health-related quality of life (HrQoL). We aimed to assess the long-term independent association of PE with HrQoL to provide reference values for interventional studies and support quantification of the burden of PE in terms of quality- or disability-adjusted life years (QALYs and DALYs). METHODS AND RESULTS: A total of 1005 patients from a prospective multicenter study, followed 3 and 12 months after PE, were successfully matched to 3058 individuals from the general population of the same country based on age, sex, and key comorbidities. Differences between acute PE survivors and matched controls in the ordinal EQ-5D-5L HrQoL dimensions were assessed using multivariable ordinal regression, in the HrQoL index (reflecting overall HrQoL) using multivariable-adjusted mixed linear regression. Both multiple imputation and complete case analysis were performed. Compared with controls, patients reported worse HrQoL in the dimensions self-care, usual activities, and anxiety/depression, and worse HrQoL index at both 3 [adjusted difference -0.04 (95% CI: -0.06, -0.039) in a range from 0 to 1] and 12 months [-0.02 (95% CI: -0.04, -0.01)] in the imputation analysis. Complete case analysis showed similar results. The annual disability weight of PE for DALY calculation was conservatively estimated at 0.03 (95% CI: 0.02, 0.04). CONCLUSION: PE was independently associated with a moderate decrease in HrQoL, which persisted 12 months after the acute episode despite partial recovery over time. This degree of impairment is comparable to that imposed by several other cardiopulmonary diseases.
No takes yet. Share an insight, caveat, or question.
Valerio et al. (2025) conducted a cohort in Pulmonary embolism (n=4,063). Pulmonary embolism vs. Matched general population controls was evaluated on Health-related quality of life (HrQoL) index (Adjusted difference -0.04, 95% CI -0.06 to -0.039). Pulmonary embolism was independently associated with worse health-related quality of life at 3 months (adjusted difference -0.04; 95% CI -0.06 to -0.039) and 12 months compared to matched controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: